|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02506 XUNFEIHEALTH
Nominal 
106.100 +2.900 (+2.810%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 298,552 | 30.255% | 733,984 | 556,125 | 471,860 | 372,452 |
| Cost of Sales | (144,684) | 33.958% | (329,900) | (241,471) | (241,191) | (184,723) |
| Gross Profit | 153,868 | 26.956% | 404,084 | 314,654 | 230,669 | 187,729 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,182) | -62.128% | (13,404) | (6,187) | (8,602) | (628) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (38,231) | (3,901) | (1,440) | (6,268) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (100,134) | -38.677% | (172,016) | (186,915) | (244,100) | (110,970) | |
| Taxation | 17,858 | -39.569% | 34,380 | 32,691 | 35,505 | 21,569 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 8,190 | 100.490% | 5,036 | 9,382 | 19,195 | 5,694 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (74,086) | -42.858% | (132,600) | (144,842) | (189,400) | (83,707) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,819 | -- | (278) | (6,749) | (2,547) | 1,088 |
| Depreciation & Amortisation | 20,887 | -10.960% | 47,925 | 41,960 | 54,232 | 36,943 |
| Directors' Emoluments | 6,643 | -31.811% | 19,048 | 29,425 | 29,402 | 12,457 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -61.000 | -46.491% | -116.000 | -130.000 | -171.000 | -90.000 |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (1.178) | (2.829) | (1.026) | (0.564) |
| NBV per share ($) | 7.294 | -- | 7.776 | -- | -- | -- |
| Remarks: | Real time quote last updated: 05/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -74,086 |
| %Change | -42.858% |
| EPS / (LPS) | RMB -0.610 |
| NBV Per Share (¥) | RMB 7.294 |